PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
6690237-4	1984	Treatment of ABPA with prednisone led to resolution of an upper lobe infiltrate and a dramatic reduction in the total serum IgE level.	Prednisone	23-33	immunoglobulin heavy constant epsilon	Homo sapiens	124-127	
10523002-7	1999	After prednisone administration, reduction in TRAb was greater in patients with normal IgE than that in patients with IgE elevation.	Prednisone	6-16	immunoglobulin heavy constant epsilon	Homo sapiens	87-90	
10523002-7	1999	After prednisone administration, reduction in TRAb was greater in patients with normal IgE than that in patients with IgE elevation.	Prednisone	6-16	immunoglobulin heavy constant epsilon	Homo sapiens	118-121	
8064074-5	1994	All of the patients had a rise in serum IgE levels after the course of prednisone (p = 0.005).	Prednisone	71-81	immunoglobulin heavy constant epsilon	Homo sapiens	40-43	
8064074-7	1994	Peripheral blood mononuclear cells from patients treated with prednisone produced increased levels of IgE in vitro when exogenous IL-4 was added to their cultures.	Prednisone	62-72	immunoglobulin heavy constant epsilon	Homo sapiens	102-105	
8064074-11	1994	These data suggest that the observed rise in IgE production associated with prednisone treatment is not clinically deleterious but reflects the immunomodulatory effects of corticosteroids on T lymphocytes.	Prednisone	76-86	immunoglobulin heavy constant epsilon	Homo sapiens	45-48	
34193062-8	2021	Treatment with oral prednisone resulted in a decrease of eosinophil, serum IgE, improvement of cardiac function, and regression of the subcutaneous mass.	Prednisone	20-30	immunoglobulin heavy constant epsilon	Homo sapiens	75-78	
19584951-8	2009	Prednisone and azathioprine treatment decreased total serum IgG, IgE, IFN-gamma and IL-4 levels, and blood CD19+ and CD23+ cells; however serum IL-12, TNFalpha and blood CD4+ T cells increased with treatment.	Prednisone	0-10	immunoglobulin heavy constant epsilon	Homo sapiens	65-68	
464387-3	1979	The exacerbations were closely correlated with sharp increases in total serum IgE, which subsequently decreased after resumption of prednisone therapy.	Prednisone	132-142	immunoglobulin heavy constant epsilon	Homo sapiens	78-81	
423017-8	1979	After prednisone was started the total serum IgE sharply declined to a plateau and remained at this level until a flare of allergic aspergillosis occurred.	Prednisone	6-16	immunoglobulin heavy constant epsilon	Homo sapiens	45-48	
645726-5	1978	(2) Treatment with alternate day prednisone (0.5 mg/kg given on alternate days) caused clinical and roentgenologic improvement as well as marked decreases in total serum IgE but does not necessarily prevent recurrence of the disease.	Prednisone	33-43	immunoglobulin heavy constant epsilon	Homo sapiens	170-173	
925820-2	1977	Initially elevated total serum IgE levels fell during prednisone therapy and rose prior to and during an exacerbation.	Prednisone	54-64	immunoglobulin heavy constant epsilon	Homo sapiens	31-34	
670610-0	1978	Relationships between prednisone therapy, disease activity, and the total serum IgE level in allergic bronchopulmonary aspergillosis.	Prednisone	22-32	immunoglobulin heavy constant epsilon	Homo sapiens	80-83